Beam Therapeutics, Inc. (BEAM)
23.99
-0.38
(-1.56%)
USD |
NASDAQ |
Sep 11, 16:00
24.02
+0.03
(+0.13%)
After-Hours: 20:00
Beam Therapeutics Market Cap : 2.477B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.477B |
| September 10, 2026 | 2.517B |
| September 09, 2026 | 2.600B |
| September 08, 2026 | 2.771B |
| September 04, 2026 | 3.063B |
| September 03, 2026 | 3.042B |
| September 02, 2026 | 3.025B |
| September 01, 2026 | 2.997B |
| August 31, 2026 | 3.039B |
| August 28, 2026 | 3.028B |
| August 27, 2026 | 3.148B |
| August 26, 2026 | 3.118B |
| August 25, 2026 | 3.204B |
| August 24, 2026 | 2.925B |
| August 21, 2026 | 3.073B |
| August 20, 2026 | 2.932B |
| August 19, 2026 | 3.002B |
| August 18, 2026 | 2.744B |
| August 17, 2026 | 2.798B |
| August 14, 2026 | 2.762B |
| August 13, 2026 | 2.738B |
| August 12, 2026 | 2.758B |
| August 11, 2026 | 2.773B |
| August 10, 2026 | 2.817B |
| August 07, 2026 | 2.838B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.814B |
| August 05, 2026 | 2.781B |
| August 04, 2026 | 2.913B |
| August 03, 2026 | 2.662B |
| July 31, 2026 | 2.622B |
| July 30, 2026 | 2.722B |
| July 29, 2026 | 2.673B |
| July 28, 2026 | 2.701B |
| July 27, 2026 | 2.576B |
| July 24, 2026 | 2.579B |
| July 23, 2026 | 2.662B |
| July 22, 2026 | 2.737B |
| July 21, 2026 | 2.804B |
| July 20, 2026 | 2.705B |
| July 17, 2026 | 2.828B |
| July 16, 2026 | 2.917B |
| July 15, 2026 | 3.169B |
| July 14, 2026 | 3.174B |
| July 13, 2026 | 3.185B |
| July 10, 2026 | 3.358B |
| July 09, 2026 | 3.680B |
| July 08, 2026 | 3.789B |
| July 07, 2026 | 3.896B |
| July 06, 2026 | 3.629B |
| July 02, 2026 | 3.574B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 7.973B |
| Prime Medicine, Inc. | 565.71M |
| Intellia Therapeutics, Inc. | 1.644B |
| Sarepta Therapeutics, Inc. | 2.160B |
| Revolution Medicines, Inc. | 43.66B |
Market Cap Related Metrics
| PS Ratio | 15.95 |
| Price to Book Value | 2.321 |
| Price | 23.99 |
| Earnings Yield | -3.58% |